 Dr Reddy’s Receives ANVISA Approval for Generic Semaglutide Injection in Brazil
MM Desk
7 November, 2026
Dr Reddy’s Laboratories Ltd has received marketing authorisation from Brazil’s National Health Surveillance Agency (ANVISA)